Indications and uses
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies: runny nose itchy, watery eyes sneezing itching of the nose or throat
adults and children 6 years and over 1 tablet daily; not more than 1 tablet in 24 hours children under 6 years of age ask a doctor consumers with liver or kidney disease ask a doctor
store between 20° to 25° C (68° to 77° F) protect from excessive moisture TAMPER EVIDENT: DO NOT USE IF BLISTER UNITS ARE TORN, BROKEN OR SHOW ANY SIGNS OF TAMPERING.
Drug Facts
Loratadine, USP 10 mg
Antihistamine
temporarily relieves these symptoms due to hay fever or other upper respiratory allergies:
Do not use if you have ever had an allergic reaction to this product or any of its ingredients.
Ask a doctor before use if you have liver or kidney disease. Your doctor should determine if you need a different dose.
When using this product do not take more than directed. Taking more than directed may cause drowsiness.
Stop use and ask a doctor if an allergic reaction to this product occurs. Seek medical help right away.
If pregnant or breast-feeding, ask a health professional before use.
Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).
| adults and children 6 years and over | 1 tablet daily; not more than 1 tablet in 24 hours |
| children under 6 years of age | ask a doctor |
| consumers with liver or kidney disease | ask a doctor |
corn starch, lactose monohydrate, magnesium stearate, pregelatinized starch
call 1-800-406-7984
Distributed by C.D.M.A., Inc.©
43157 W. Nine Mile
Novi, MI 48376-0995
QUALITY
CHOICE
NDC 63868-151-30
†Compare to
Active Ingredient in
CLARITIN®
Original Prescription Strength
Allergy Relief
Loratadine Tablets, USP
10 mg | Antihistamine
Indoor & Outdoor Allergies
Relief of:
Sneezing | Runny Nose
Itchy, Watery Eyes | Itchy Throat or Nose
24 Hour Allergy Relief | Non-Drowsy*
30 Tablets
*When taken as directed. See Drug Facts Panel.

| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63868-151-01 | Loratadine | 100 in 1 BOTTLE | TABLET | 100 | 2 | |
| 63868-151-10 | Loratadine | 10 in 1 BLISTER PACK | TABLET | 10 | 2 | |
| 63868-151-30 | Loratadine | 30 in 1 BLISTER PACK | TABLET | 30 | 2 |
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63868-151-01 | EA - Each | 63868-151 | 2c4c2054-3f6a-4480-b142-9b9acb886c88 | 1 | 2013-02-13 |
| 63868-151-10 | EA - Each | 63868-151 | 02979198-ba24-4bde-8e24-cd0fae20aa9a | 1 | 2013-02-13 |
| 63868-151-30 | EA - Each | 63868-151 | 7a13a994-3214-4a6d-a823-03fb8b4454ba | 1 | 2013-02-13 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| LORATADINE | ACTIVE INGREDIENT | 7AJO3BO7QN | 1 | |
| LORATADINE | ACTIVE MOIETY | 7AJO3BO7QN | 1 | |
| LACTOSE MONOHYDRATE | INACTIVE INGREDIENT | EWQ57Q8I5X | 1 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | 1 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | 1 | |
| STARCH, PREGELATINIZED CORN | INACTIVE INGREDIENT | O8232NY3SJ | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63868-151 | 63868-151-10, 63868-151-30, 63868-151-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| LORATADINE | 7AJO3BO7QN | ACTIB |
| STARCH, CORN | O8232NY3SJ | IACT |
| LACTOSE MONOHYDRATE | EWQ57Q8I5X | IACT |
| MAGNESIUM STEARATE | 70097M6I30 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| LACTOSE MONOHYDRATE | LACTOSE MONOHYDRATE | EWQ57Q8I5X | TABLET / ORAL | 4384 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| MAGNESIUM STEARATE | MAGNESIUM STEARATE | 70097M6I30 | TABLET / ORAL | 980 mg | ||
| STARCH, CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg | ||
| STARCH, PREGELATINIZED CORN | STARCH, CORN | O8232NY3SJ | TABLET / ORAL | 1116 mg |
All distinct exact application/product contexts derived from this label’s complete NDC list are paginated below.
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A076134-001 | LORATADINE | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 |
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 84e616aacf4f… | ||
| 2026-08-18 06:07:40 | 2026-07 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | caaa826d4ba7… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | 3a93d1ddd44b… | ||
| 2022-10-28 04:53 UTC | 2022-10 | A076134-001 | LORATADINE | 10MG | TABLET / ORAL | 2003-08-18 | f41ea6bd6efb… |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Loratadine | LORATADINE | Chain Drug Marketing Association Inc. | b4edf5b1-398d-405a-8a42-76044b31ebb7 | 2018-08-27 | Warnings | 63868-151-30 63868-151-01 63868-151-10 63868-151 63868015101 63868015130 63868015110 08f2bf78-eba5-41ce-bcb0-733e2760d44b b4edf5b1-398d-405a-8a42-76044b31ebb7 |
Adverse event summaries are temporarily unavailable. Other product information remains available.